Visit KNAUER at 5th LNP Formulation & Process Development Summit in Boston!

As the LNP field continues to expand, from mRNA vaccines to cutting-edge cell and gene therapies, the 5th LNP Formulation & Process Development Summit returns to Boston in April 2026. Curated in collaboration our Scientific Advisory Board, Annette Bak (AstraZeneca), Luis Brito (Beam Therapeutics), and Ching Kim Tye (Sanofi), this premier forum is designed to deliver LNP-specific networking and knowledge sharing.

Join LNP innovators to advance extrahepatic targeting, stable formulation design, robust analytical characterization, and consistent large-scale manufacturing to accelerate LNP-based therapeutics to the market.